Nimbus, Lilly sign deal to develop new oral obesity drug

Group 1 - Nimbus Therapeutics has entered into a multi-year research and licensing agreement with Eli Lilly [1] - The focus of the collaboration is to develop artificial intelligence-driven new oral treatments for obesity and other conditions [1]